Belantamab Mafodotin
Records for this ingredient, by country (identity only).
ATC L01FX15 · 9 markets · 19 records
GB 3 records · 2 shown of 2
- 100 mg per mL / per unit basis not statedinjectionBlenrep 100mg powder for concentrate for solution for infusion vials
- 70 mg per mL / per unit basis not statedinjectionBlenrep 100mg powder for concentrate for solution for infusion vials
AU 3 records · 2 shown of 2
- 100 mg per mL / per unit basis not statedinjectionBLENREP belantamab mafodotin 100 mg powder for injection vial
- 70 mg per mL / per unit basis not statedinjectionBLENREP belantamab mafodotin 100 mg powder for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 2 shown of 2
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 2 records · 2 shown of 2
- 100 mg per mL / per unit basis not statedinjectionブーレンレップ点滴静注用70mg
- 70 mg per mL / per unit basis not statedinjectionブーレンレップ点滴静注用70mg
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 50 mg per mL / per unit basis not statedinjectionBlenrep
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|
| 100 mg per mL / per unit basis not stated cannot compare injection | Blenrep 100mg powder for concentrate for solution for infusion vials | BLENREP belantamab mafodotin 100 mg powder for injection vial | Blenrep | ブーレンレップ点滴静注用70mg | |||||
| 70 mg per mL / per unit basis not stated cannot compare injection | Blenrep 100mg powder for concentrate for solution for infusion vials | BLENREP belantamab mafodotin 100 mg powder for injection vial | Blenrep | ブーレンレップ点滴静注用70mg | |||||
| 50 mg per mL / per unit basis not stated cannot compare injection | Blenrep | ||||||||
| 100 mg powder | Blenrep | ||||||||
| 70 mg powder | Blenrep | ||||||||
unknown | Blenrep | BLENREP Powder for Concentrate for Solution for Infusion | Blenrep | ||||||
injection | BLENREP Powder for Concentrate for Solution for Infusion 倍力銳凍晶注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 TW 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.